Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Results 1 - 20 of 37 : 1 2 Next »

Recs

0
Member Avatar marsuculix (< 20) Submitted: 5/23/2013 7:19:49 AM : Outperform Start Price: $79.86 PCYC Score: +5.54

ASCO 2013 provides upside potential !

Recs

0
Member Avatar 50daymovingshort (33.75) Submitted: 4/10/2013 5:11:33 AM : Underperform Start Price: $75.45 PCYC Score: -7.36

This pick was made because its below the 50day moving average as of April 10th.
The whole list I perused through below 50dmva for 4/10/13 were;
AMZN,SIRI,PRAN,PCYC,CNQR,PCLN,CRM,LULU,CVLT,NFLX,ULTI,CTXS

These tickers were picked from my tracking universe of the following tickers:
CCI,AMZN,SIRI,LMT,PNRA,SBAC,RPRX,PRAN,MDVN,VZ,ALXN,PCYC,CNQR,INFI,VRTX,PCLN,CRM,LULU,CVLT,NFLX,OPEN,GMCR,N,CAR,REGN,T,SBUX,MO,ULTI,MAR,EQIX,CTXS,CLH,BLL

This was supposed to be a simple tracking blog post rather than a pitch but as a new player, it takes a couple of days to be approved for blog posting...oh well. Hopefully I remember to look back at these pitches.

Recs

0
Member Avatar mchedester (49.57) Submitted: 3/22/2013 4:47:10 PM : Outperform Start Price: $80.64 PCYC Score: -0.69

Great company with lots of cash that has been shooting up for a long time. I bought on the dip today and I'm buying in my motley fool caps as well.

Recs

0
Member Avatar buckeyefanboy (94.24) Submitted: 2/11/2013 12:52:10 PM : Outperform Start Price: $70.19 PCYC Score: +11.94

They're finally profitable and they got profitable in a big way.

Recs

0
Member Avatar PrototypeZ (< 20) Submitted: 2/4/2013 5:27:10 PM : Underperform Start Price: $70.30 PCYC Score: -10.82

Price levels are out of whack with fundamentals

Recs

0
Member Avatar tiredofit (< 20) Submitted: 1/30/2013 6:36:23 PM : Outperform Start Price: $68.01 PCYC Score: +14.57

outperform

Recs

1
Member Avatar lewrose (69.55) Submitted: 12/23/2012 1:37:57 PM : Outperform Start Price: $60.25 PCYC Score: +24.94

Game changing medication for several forms of leukemia, including CLL, about to be approved by FDA.

Recs

0
Member Avatar portefeuille (99.75) Submitted: 12/18/2012 10:53:43 PM : Outperform Start Price: $67.72 PCYC Score: +8.78

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

Recs

8
Member Avatar SkepBioInvestor (73.37) Submitted: 10/9/2012 4:15:21 PM : Outperform Start Price: $65.33 PCYC Score: +15.33

1 star caps rating? another reason why we should not rely on the so called TMF pros. Good lesson of humility for some of them.

Immunokinases are a hot target these days, as hot as the multibillion market opportunity of hematological cancers. Of course, any safety/efficacy issues and the stock will tank hard

Recs

0
Member Avatar Imhilion (67.89) Submitted: 9/18/2012 12:24:21 AM : Underperform Start Price: $63.14 PCYC Score: -21.66

Parabolic technicals, stupidly overvalued fundamentals

Recs

0
Member Avatar BuffettJunior1 (98.10) Submitted: 9/15/2012 7:35:39 PM : Underperform Start Price: $62.41 PCYC Score: -23.58

Why is this stock valued as if all of the company's drugs have been approved? Ridiculous valuation for an early stage biotech!

Recs

1
Member Avatar BigFatBEAR (30.12) Submitted: 8/21/2012 1:56:17 AM : Underperform Start Price: $61.18 PCYC Score: -22.84

Eegads... don't think I've ever seen so many highly-ranked fools with -1000+ points associated as with this stock. Maybe shipping or solar, back in the day. Anyway, underperform...

Recs

0
Member Avatar jwray01 (99.63) Submitted: 7/18/2012 6:38:18 AM : Underperform Start Price: $53.04 PCYC Score: -38.63

one anomolous quarter is pumping up their earnings and stock price. None of their drugs have even started stage 3 trials yet. Stock spammers love them.

Recs

0
Member Avatar TMFBiologyFool (99.15) Submitted: 7/2/2012 1:38:57 PM : Underperform Start Price: $57.52 PCYC Score: -26.12

Ibrutinib has potential, but risk reward is too unfavorable after the run up.

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:06:59 PM : Outperform Start Price: $53.90 PCYC Score: +32.62

went to 300% increase for potofeille.

Recs

1
Member Avatar GoodTrader1 (< 20) Submitted: 6/6/2012 4:38:42 PM : Outperform Start Price: $35.79 PCYC Score: +113.59

high relative strenght

Recs

2
Member Avatar wabiri (< 20) Submitted: 2/13/2012 4:16:29 PM : Outperform Start Price: $25.07 PCYC Score: +216.65

I think pcyc will hit $50.00 in 5years.

Recs

0
Member Avatar justaboutperfect (25.33) Submitted: 2/13/2012 8:59:12 AM : Underperform Start Price: $25.10 PCYC Score: -216.28

What happens to a shooting star when it has no FDA approvals on products. It will need more cash to burn...

Recs

0
Member Avatar ExtremesTracker (83.14) Submitted: 2/9/2012 10:44:36 PM : Underperform Start Price: $19.60 PCYC Score: -310.59

Skyrocketed based on expectations; no tangible results & more lofty expectations based on today's valuation compared to most other biotechs

Recs

1
Member Avatar NuclearSteve (54.12) Submitted: 1/25/2012 12:42:43 PM : Outperform Start Price: $18.36 PCYC Score: +337.41

Strictly going off the genius Baker Brothers buying the stock. The fundamentals of this company look like any other infant-stage biotech... awful.

Results 1 - 20 of 37 : 1 2 Next »

Featured Broker Partners


Advertisement